Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Monkeys with more anxious or inhibited temperaments tend to have less hair loss.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Children with trichotillomania often pull hair from their scalp and may have other mental health issues.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Alopecia areata negatively affects self-esteem, relationships, and academics in young people.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

People who are more materialistic often expect life changes from buying things, leading to more debt and credit misuse.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Pegvaliase is recommended for treating adults with phenylketonuria.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Laser hair removal improves quality of life but emotional benefits decrease over time, suggesting more treatments are needed for lasting effects.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

A model called PM-DBiGRU was developed for analyzing sentiments in drug reviews, and it performed better than other models, but struggled with complex sentences and situations requiring background knowledge.